Inlyta (axitinib tablets - Pfizer) — Cigna
Soft tissue sarcoma (alveolar soft part sarcoma)
Initial criteria
- Patient is age ≥ 18 years
- Patient has alveolar soft part sarcoma
- Medication will be used in combination with Keytruda (pembrolizumab intravenous infusion)
Approval duration
1 year